Real-time quantification of bcr-abl transcript in chronic myeloid leukaemia patients after allogenic stem cell transplantation

被引：0
|
作者：
Ghaffari, SH [1 ]
Yaghmaie, M [1 ]
Alimoghadam, K [1 ]
Ghavamzadeh, A [1 ]
机构：
[1] Univ Tehran Med Sci, Tehran, Iran
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S356 / S356
页数：1
相关论文
共 50 条
  • [41] Is the BCR-ABL1 transcript type in chronic myeloid leukaemia relevant?
    Stephen E. Langabeer
    Medical Oncology, 2013, 30
  • [42] Is the BCR-ABL1 transcript type in chronic myeloid leukaemia relevant?
    Langabeer, Stephen E.
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [43] Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients
    Bianchini, Michele
    De Brasi, Carlos
    Gargallo, Patricia
    Gonzalez, Mariana
    Bengio, Raquel
    Larripa, Irene
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (04) : 292 - 300
  • [44] Variable significance of low levels of Bcr-Abl transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukaemia in chronic phase
    O'Shea, DM
    Kaeda, J
    Szydlo, R
    Olavarria, E
    Marin, D
    Dazzi, F
    Perz, JB
    Anand, M
    Saunders, S
    Goldman, JM
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2005, 35 : S68 - S69
  • [45] Response to Imatinib Treatment in Chronic Myeloid Leukemia According to BCR-ABL Transcript
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S242 - S243
  • [46] Chronic Myeloid Leukemia: Clinical Prestantation According to Bcr-Abl Transcript Variants
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S243 - S243
  • [47] PREVALENCE OF BCR-ABL IMATINIB RESISTANT MUTATIONS IN PORTUGUESE CHRONIC MYELOID LEUKAEMIA (CML) PATIENTS
    Palmeiro, A.
    Torres, F.
    Lemos, R.
    Teixeira, M.
    Gabriel, H.
    Rendeiro, P.
    Tavares, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 539 - 539
  • [48] Detection of BCR-ABL transcript by quantitative real-time PCR and Amp-CML (Transcript mediated amplification) during imatinib therapy for chronic myeloid leukemia.
    Miyamura, Koichi
    Yagasaki, Fumiharu
    Kyo, Taiichi
    Ohnishi, Kazunori
    Naoe, Tomoki
    Takeuchi, Hitoshi
    Nishimura, Miki
    Fujiwara, Shin
    Tauchi, Tetsuzo
    Ohno, Ryuzo
    BLOOD, 2006, 108 (11) : 282B - 282B
  • [49] Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion
    Otazú, IB
    Tavares, RDB
    Hassan, R
    Zalcberg, I
    Tabak, DG
    Seuánez, HN
    LEUKEMIA RESEARCH, 2002, 26 (02) : 129 - 141
  • [50] The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia
    Wang, LH
    Knight, K
    Lucas, C
    Clark, RE
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 235 - 239
12345